Viewing Study NCT00215956


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2025-12-25 @ 9:17 PM
Study NCT ID: NCT00215956
Status: COMPLETED
Last Update Posted: 2013-12-23
First Post: 2005-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2001-11
Start Date Type: None
Primary Completion Date: 2008-01
Primary Completion Date Type: ACTUAL
Completion Date: 2008-01
Completion Date Type: ACTUAL
First Submit Date: 2005-09-19
First Submit QC Date: None
Study First Post Date: 2005-09-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-12-20
Last Update Post Date: 2013-12-23
Last Update Post Date Type: ESTIMATED